• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼压对高分子量化合物经巩膜扩散的影响。

The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds.

作者信息

Cruysberg Lars P J, Nuijts Rudy M M A, Geroski Dayle H, Gilbert Jake A, Hendrikse Fred, Edelhauser Henry F

机构信息

Department of Ophthalmology, Emory University, Atlanta, GA 30322, USA.

出版信息

Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3790-4. doi: 10.1167/iovs.04-1414.

DOI:10.1167/iovs.04-1414
PMID:16186364
Abstract

PURPOSE

To evaluate the effects of intraocular pressure on the permeability of the human sclera to high-molecular-weight compounds.

METHODS

Human transscleral permeability to FITC-albumin (70 kDa) and 70-kDa and 150-kDa FITC-dextran was determined at transscleral pressures from 0 to 60 mm Hg. For each compound at each pressure, six to eight experiments were performed. Scleral sections were mounted in a two-compartment perfusion chamber. Temperature was maintained at 37 degrees C. Fractions of choroidal perfusate were collected, and fluorescence was measured with a spectrofluorometer. From these data, scleral permeability K(trans) (in centimeters per second) was calculated.

RESULTS

Permeability to FITC-albumin was decreased by approximately one half when pressure was elevated from 0 to 30 mm Hg (P < 0.05). No significant differences in permeability to 70-kDa FITC-dextran were observed at pressures from 0 to 60 mm Hg. Permeability to 150-kDa FITC-dextran decreased by a little more than one half when transscleral pressure was raised from 0 to 15 mm Hg and was approximately 10 times lower at 60 mm Hg than at 0 mm Hg (P < 0.01).

CONCLUSIONS

Human sclera was permeable to compounds with a molecular weight of up to 150 kDa at transscleral pressures ranging from 0 to 60 mm Hg. Transscleral diffusion was relatively unaffected by the pressure gradient, although for 150-kDa FITC-dextran at 60 mm Hg a 10-fold decrease was observed compared with that at 0 mm Hg. These experiments suggest that high-molecular-weight compounds (e.g., immunoglobulins and oligonucleotides) could be effectively delivered transsclerally to the intraocular tissues under circumstances of physiological or elevated intraocular pressure.

摘要

目的

评估眼压对人巩膜对高分子量化合物通透性的影响。

方法

在0至60毫米汞柱的经巩膜压力下,测定人经巩膜对异硫氰酸荧光素标记的白蛋白(70 kDa)以及70 kDa和150 kDa异硫氰酸荧光素标记的葡聚糖的通透性。对于每种化合物在每个压力下,进行六至八次实验。将巩膜切片安装在双室灌注室中。温度维持在37摄氏度。收集脉络膜灌注液的馏分,并用荧光分光光度计测量荧光。根据这些数据,计算巩膜通透性K(trans)(以厘米每秒为单位)。

结果

当压力从0升高至30毫米汞柱时,对异硫氰酸荧光素标记的白蛋白的通透性降低了约一半(P < 0.05)。在0至60毫米汞柱的压力下,未观察到对70 kDa异硫氰酸荧光素标记的葡聚糖的通透性有显著差异。当经巩膜压力从0升高至15毫米汞柱时,对150 kDa异硫氰酸荧光素标记的葡聚糖的通透性降低了略超过一半,并且在60毫米汞柱时比在0毫米汞柱时低约10倍(P < 0.01)。

结论

在0至60毫米汞柱的经巩膜压力范围内,人巩膜对分子量高达150 kDa的化合物具有通透性。经巩膜扩散相对不受压力梯度的影响,尽管对于60毫米汞柱下的150 kDa异硫氰酸荧光素标记的葡聚糖,与0毫米汞柱时相比观察到降低了10倍。这些实验表明,在生理眼压或眼压升高的情况下,高分子量化合物(例如免疫球蛋白和寡核苷酸)可以有效地经巩膜递送至眼内组织。

相似文献

1
The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds.眼压对高分子量化合物经巩膜扩散的影响。
Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3790-4. doi: 10.1167/iovs.04-1414.
2
Diffusion of high molecular weight compounds through sclera.高分子量化合物通过巩膜的扩散。
Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1181-5.
3
Diffusion of macromolecules through sclera.大分子通过巩膜的扩散。
Acta Ophthalmol. 2013 Feb;91(1):e1-6. doi: 10.1111/j.1755-3768.2012.02557.x. Epub 2012 Sep 23.
4
Influence of molecular shape, conformability, net surface charge, and tissue interaction on transscleral macromolecular diffusion.分子形状、顺应性、净表面电荷和组织相互作用对巩膜透性大分子扩散的影响。
Exp Eye Res. 2012 Sep;102:85-92. doi: 10.1016/j.exer.2012.07.007. Epub 2012 Jul 27.
5
Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity.视网膜色素上皮的通透性:渗透分子分子量和亲脂性的影响。
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):641-6. doi: 10.1167/iovs.04-1051.
6
The effect of intraocular pressure on human and rabbit scleral permeability.眼压对人及兔巩膜通透性的影响。
Invest Ophthalmol Vis Sci. 1999 Nov;40(12):3054-8.
7
Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab.人巩膜屏障特性的表征及其在贝伐单抗和雷珠单抗经巩膜递药中的应用。
J Pharm Sci. 2013 Mar;102(3):892-903. doi: 10.1002/jps.23387. Epub 2012 Dec 4.
8
Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome.葡萄膜渗漏综合征患者的巩膜水导率和大分子扩散
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):5033-40. doi: 10.1167/iovs.08-1980. Epub 2008 Jun 14.
9
In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits.体内眼荧光光度测定:荧光右旋糖酐经兔巩膜扩散递药。
Invest Ophthalmol Vis Sci. 2011 Sep 1;52(10):7038-45. doi: 10.1167/iovs.11-7207.
10
Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.人巩膜通透性。年龄、冷冻疗法、经巩膜二极管激光及手术变薄的影响。
Invest Ophthalmol Vis Sci. 1995 Aug;36(9):1893-903.

引用本文的文献

1
Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab.Ranibizumab 经巩膜递药的脂质体载体的特性研究。
Sci Rep. 2017 Dec 1;7(1):16803. doi: 10.1038/s41598-017-16791-7.
2
A review of collagen cross-linking in cornea and sclera.角膜和巩膜中胶原交联的综述。
J Ophthalmol. 2015;2015:289467. doi: 10.1155/2015/289467. Epub 2015 Apr 2.
3
Comparison of riboflavin/ultraviolet-A cross-linking in porcine, rabbit, and human sclera.猪、兔和人巩膜中核黄素/紫外线A交联的比较
Biomed Res Int. 2014;2014:194204. doi: 10.1155/2014/194204. Epub 2014 Jan 2.
4
Evaluation of tissue interactions with mechanical elements of a transscleral drug delivery device.评估巩膜给药装置机械元件与组织的相互作用。
Pharmaceutics. 2012 Mar 12;4(1):212-29. doi: 10.3390/pharmaceutics4010212.
5
Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability.猪巩膜作为人巩膜的体外转运实验模型:组织学、扫描电子显微镜及通透性比较
Mol Vis. 2009;15:259-66. Epub 2009 Feb 6.
6
Drug delivery to posterior intraocular tissues: third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.药物递送至眼内后部组织:第三届ARVO/辉瑞眼科研究所年度会议
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4712-20. doi: 10.1167/iovs.08-1904. Epub 2008 Aug 15.